Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

MRT is not legal in the U.S. But medical tourism agencies charge thousands of dollars to connect women to clinics around the ...

Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government ...